Stem Cell‐Derived Cardiac and Conduction System Cells for Heart Regeneration and Repair: Current Progress and Future Directions
Journal of the American Heart Association · 01.09.2026 · 15 (17)
DOI: 10.1161/jaha.126.050981 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 01.09.2026. Verfasst von Berra Koskulu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological and Pharmaceutical Sciences College of Pharmacy, University of Houston Houston TX USA. Hauptthemen laut MEDLINE: Regeneration, Induced Pluripotent Stem Cells, Myocytes, Cardiac, Regenerative Medicine. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Cardiovascular disease remains the leading cause of global mortality, in part because the heart has limited regenerative capacity. Human‐induced pluripotent stem cells (hiPSCs) offer a scalable, patient‐specific platform for modeling heart disease, advancing drug discovery, and developing regenerative therapies. This review evaluates recent developments in hiPSC technology, beginning with the generation of patient‐specific models of inherited arrhythmias and cardiomyopathies. We examine progress in directing hiPSCs into specialized lineages, including cardiomyocytes, pacemaker cells, and Purkinje fibers, by highlighting key developmental signaling pathways and transcriptional regulators. Furthermore, we discuss emerging strategies for cell and therapeutic delivery, such as bioengineered patches and hydrogels, and address key challenges in cell maturation and functional integration. Finally, we review current clinical trials assessing the safety of hiPSC‐based treatments for heart failure and conduction disorders. These advancements underscore the dual potential of hiPSCs as essential research tools and as aspirational therapeutic resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacological and Pharmaceutical Sciences College of Pharmacy, University of Houston Houston TX USA.
- Department of Medicine Cardiovascular Research Institute, Baylor College of Medicine Houston TX USA.
- Department of Biology and Biochemistry College of Natural Science and Mathematics, University of Houston Houston TX USA.
- Escuela Superior de Medicina/Instituto Politécnico Nacional Ciudad de México México.
ORCID-Profile: Berra Koskulu, Tabish Ali, Ilkin Tetik-Altintop, Bradley K McConnell
Förderung
- NHLBI NIH HHS
Zitieren
APA
Koskulu, B., Ali, T., Tetik-Altintop, I., Villanueva, C., Gomola, M., & McConnell, B. K. (2026). Stem Cell‐Derived Cardiac and Conduction System Cells for Heart Regeneration and Repair: Current Progress and Future Directions. Journal of the American Heart Association, 15(17). https://doi.org/10.1161/jaha.126.050981
Vancouver
Koskulu B, Ali T, Tetik-Altintop I, Villanueva C, Gomola M, McConnell BK. Stem Cell‐Derived Cardiac and Conduction System Cells for Heart Regeneration and Repair: Current Progress and Future Directions. Journal of the American Heart Association. 2026;15(17). doi:10.1161/jaha.126.050981
BibTeX
@article{Koskulu2026,
author = {Koskulu, Berra and Ali, Tabish and Tetik-Altintop, Ilkin and Villanueva, Cleva and Gomola, Maja and McConnell, Bradley K},
title = {Stem Cell‐Derived Cardiac and Conduction System Cells for Heart Regeneration and Repair: Current Progress and Future Directions},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {17},
doi = {10.1161/jaha.126.050981}
}
EUVIMED